Raul Andino

Raul Andino is a virologist and professor in the Department of Microbiology and Immunology at the University of California, San Francisco.[1] He is noted for leading a team of researchers that developed the first new oral polio vaccine in 50 years.[2]

Raul Andino
Born1957
Academic background
Academic advisorsDavid Baltimore
Academic work
Doctoral studentsShane Crotty (2001)

Early life and education

Raul Andino was born in 1957[3] in Argentina[4]. He completed his Masters Degree in Biology in 1980 and his Ph.D. in Chemistry in 1986, both at the University of Buenos Aires.[1]

Andino emigrated to the United States in the 1980s.[4] He then went on to work as a postdoctoral researcher first at the Whitehead Institute for Biomedical Research from 1986 to 1991, then at Rockefeller University in the lab of David Baltimore from 1991 to 1992.[1] He then joined the faculty of the University of California, San Francisco as an assistant professor.[1] He was promoted to associate professor in 1999, then full professor in 2003.[1]

Research

Raul Andino's research has long focused on poliovirus. Together with Andrew Macadam, Andino redesigned the polio vaccine so it can stop the virus from re-evolving.[5][6] His research has expanded to other enteroviruses and host defenses against other RNA viruses.[3] His group has also had a long-standing interest in RNA interference as an antiviral defense, and in the dynamics of viral evolution during infection and transmission.[3]

Notable publications
  • Vignuzzi M, Stone JK... Andino R (2006). Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature. 439(7074): pgs. 344-348
  • Gitlin L, Karelsky S, Andino R (2002). Short interfering RNA confers intracellular antiviral immunity in human cells. Nature. 418(6896): pgs. 430-434
  • Crotty S, Camerson SE, Andino R (2001). RNA virus error catastrophe: direct molecular test using ribavirin. Proceedings of the National Academy of Sciences of the United States of America. 98(12): pgs. 6895-6900
  • Gamarnik AV, Andino R (1998). Switch from translation to RNA replication in a positive-stranded RNA virus. Genes and Development. 12(15) pgs. 2293-2304
  • Andino R, Rieckhof GE... Baltimore D (1993). Poliovirus RNA synthesis utilizes an RNP complex formed around the 5'-end of the viral RNA. EMBO Journal. 12(9): pgs. 3587-3598
gollark: Neither.
gollark: Do you like the emojis?
gollark: You get access to """"""moderator"""""" channels.
gollark: """"""moderator"""""", obviously?
gollark: Welcome, "R"azetime!

References
  1. "Raul Andino, PhD". UCSF. Retrieved 11 July 2019.
  2. "'Designer Virus' is First New Polio Vaccine in 50 Years". ‘Designer Virus’ is First New Polio Vaccine in 50 Years | UC San Francisco. Retrieved 2020-06-23.
  3. "Academy Beijerinck Prize for American Virologyo Raul Andino". Koninkllejke Nederlandse Akademie van Wetenschappen. 27 February 2017. Retrieved 11 July 2019.
  4. Christian, Carlos (2020-06-12). "The first polio vaccine in half a century reactivates the hope of eradicating a disease again | Future Planet | The Union Journal". Retrieved 2020-06-23.
  5. Rees, Victoria (April 28, 2020). "Researchers design first new polio vaccine in 50 years". EPR. Retrieved June 24, 2010.
  6. Kaltwasser, Jared (May 4, 2020). "New Oral Polio Vaccine Candidate Could Signal Strategy to Fight COVID-19". ContagionLive. Retrieved 2020-06-23.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.